SEC Form 4 · accession 0001209191-18-039531
Denali Therapeutics Inc. · DNLI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Alexander O. Schuth
Officer — COO and Secretary
Period of report
Jun 22, 2018
Accepted (ET)
Jun 26, 2018 · 5:38 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001714899
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 22, 2018 | M | 5,918 | $5.28 | A | 5,918 | D | |
| Common StockF1 | holding | — | — | — | 685,089 | I | See footnote |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2 | $5.28 | Jun 22, 2018 | M | 5,918 | D | — | Mar 7, 2027 | Common Stock | 5,918 | 119,082 | D |
Explanation of responses
- F1The shares are held of record by the Schuth Family Trust, for which the Reporting Person serves as trustee.
- F225% of the shares subject to the option vested on March 8, 2018 and an additional 1/48 of the shares vest monthly thereafter.